Expression of cGMP-dependent protein kinase I and its substrate VASP in neointimal cells of the injured rat carotid artery

European Journal of Clinical Investigation

Volumn 28, Issue 5, 1998, Pages 416-423

  Monks D ^a   Lange, V ^b   Silber, R E ^b   Markert, T ^a   Walter, U ^a   Nehls, V ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

cGMP dependent protein kinase; Neointima; Restenosis; Smooth muscle cell; Vasodilator stimulated phosphoprotein

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTICLE; CAROTID ARTERY; CELL MOTILITY; CONTROLLED STUDY; CYTOSKELETON; ENZYME SUBSTRATE; IMMUNOHISTOCHEMISTRY; INTIMA; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TARGET CELL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANIMALS; BALLOON DILATATION; CAROTID ARTERIES; CELL ADHESION MOLECULES; CYCLIC GMP-DEPENDENT PROTEIN KINASES; MALE; MICROFILAMENT PROTEINS; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TUNICA INTIMA;

EID: 0031840731     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00308.x     Document Type: Article

References (58)

1. Block PC. Restenosis after percutaneous transluminal coronary angioplasty: anatomic and pathophysiological mechanism - strategies for prevention. Circulation 1990; 81 (Suppl. IV): 2-4.
2. Liu MW, Roubin GS, King SB. Restenosis after coronary angioplasty: the potential biologic determinants and role of intimai hyperplasia. Circulation 1989; 79: 1373-87.
3. Schwartz SM, deBlois D, O'Brien ERM. The intima. Soil for atherosclerosis and restenosis. Circ Res 1995; 77: 445-65.
4. Casscells W. Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 1992; 86: 723-9.
5. Clowes AW, Clowes MM, Reidy MA. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest 1986; 54: 295-303.
6. Clowes AW, Schwartz SM. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res 1985; 56: 139-45.
7. Clowes AW, Reidy MA. Kinetics of cellular proliferation after arterial injury. I. smooth muscle growth in the absence of endothelium. Lab Invest 1983; 49: 327-33.
8. Clowes AW, Reidy MA, Clowes MM. Mechanism of stenosis after arterial injury. Lab Invest 1983; 49: 208-15.
9. Fingerle J, Au YP, Clowes AW, Reidy MA. Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis 1990; 10: 1082-7.
10. Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 1990; 87: 4600-4.
11. Schwartz SM, Liaw L. Growth control and morphogenesis in the development and pathology of arteries. J Cardiovasc Pharmacol 1993; 21: S31-S49.
12. Butt E, Geiger J, Jarchau T, Lohmann SM, Walter U. The cGMP-dependent protein kinase-gene, protein, and function. Neurochem Res 1993; 18: 27-42.
13. Lincoln TM, Komalavilas P, Boerth NJ et al. cGMP signaling through cAMP-and cGMP-dependent protein kinases. Adv Pharmacol 1995; 34: 305-22.
14. Lincoln TM, Komalavilas P, Cornwell TL. Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension 1994; 23: 1141-7.
15. Lohmann SM, Vaandrager AB, Smolenski A et al. Separate functions of cGMP-dependent protein kinases. Trends Biol Sci 1997; 22: 307-12.
16. Walter U. Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. Rev Physiol Biochem Pharmacol 1989; 113: 42-88.
17. Cornwell TL, Pryzwanski KB, Wyatt TA, Lincoln TM. Regulation of sarcoplasmatic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells. Mol Pharmacol 1991; 40: 923-31.
18. Cornwell TL, Lincoln TM. Regulation of intracellular Ca2+ levels in cultured vascular smooth muscle cells. Reduction of Ca2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cGMP-dependent protein kinase. J Biol Chem 1989; 264: 1146-55.
19. Walter U. Distribution of cyclic GMP-dependent protein kinase in various rat tissues and cell lines determined by a sensitive and specific radioimmunoassay. Eur J Biochem 1981; 118: 339-46.
20. Lohmann SM, Walter U, Miller PE, Greengard P, DeCamilli P. Immunohistochemical localization of cyclic GMP-dependent protein kinase in mammalian brain. Proc Natl Acad Sci USA 1981; 78: 653-7.
21. Geiger J, Nolte C, Butt E, Sage SO, Walter U. Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. Proc Natl Acad Sci USA 1992; 89: 1031-5.
22. Waldmann R, Bauer S, Göbel C et al. Demonstration of cGMP-dependent protein kinase and cGMP-dependent phosphorylation in cell-free extracts of platelets. Eur J Biochem 1986; 158: 203-10.
23. Joyce NC, DeCamilli P, Boyles J. Pericytes, like vascular smooth muscle cells, are immunocytochemically positive for cyclic GMP-dependent protein kinase. Microvasc Res 1984; 28: 206-19.
24. Markert T, Krenn V, Leebmann J, Walter U. High expression of the focal adhesion-and microfilament-associated protein VASP in vascular smooth muscle and endothelial cells of the intact human vessel wall. Bas Res Cardiol 1996; 91: 337-43.
25. Draijer R, Vaandrager AB, Nolte C et al. Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Circ Res 1995; 77: 897-905.
26. Gambaryan S, Häusler C, Marken T et al. Expression of type II cGMP-dependent protein kinase in rat kidney is regulated by dehydration and correlated with renin gene expression. J Clin Invest 1996; 98: 662-70.
27. Jarchau T, Häusler C, Markert T et al. Cloning, expression, and in situ localization of rat intestinal cGMP-dependent protein kinase II. Proc Natl Acad Sci USA 1994; 91: 9426-30.
28. Markert T, Vaandrager AB, Gambaryan S et al. Endogenous expression of type II cGMP-dependent protein kinase mRNA and protein in rat intestine - implications for cystic fibrosis transmembrane conductance regulator. J Clin Invest 1995; 96: 822-30.
29. Cornwell TL, Arnold E, Boerth NJ, Lincoln TM. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol 1994; 267: C1405-C1413.
30. Dubey RK, Jackson EK, Lüscher TF. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cells. J Clin Invest 1995; 96: 141-9.
31. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-7.
32. Garg UC, Hassid A. Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. Am J Physiol 1989; 257: F60-6.
33. Sarkar R, Meinberg EG, Stanley JC et al. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 1996; 78: 225-30.
34. Appel RG. Growth-regulatory properties of atrial natriuretic factor. Am J Physiol 1992; 262: F911-18.
35. Leyen von der HE, Gibbons GH, Morishita R et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 1995; 92: 1137-41.
36. Radomski MW, Moncada S. Regulation of vascular homeostasis by nitric oxide. Thromb Haemostas 1993; 70: 36-41.
37. Schmidt HHHW, Walter U. NO at work. Cell 1994; 78: 919-25.
38. Haffner C, Jarchau T, Reinhard M et al. Molecular cloning, structural analysis and functional expression of the proline-rich focal adhesion and microfilament-associated protein VASP. EMBO J 1992; 11: 2063-70.
39. Halbrügge M, Walter U. Purification of a vasodilator-regulated phosphoprotein from human platelets. Eur J Biochem 1989; 185: 41-50.
40. Reinhard M, Halbrügge M, Scheer U et al. The 46/50 kDa phosphoprotein VASP purified from human platelets is a novel protein associated with actin filaments and focal contacts. EMBO J 1992; 11: 2063-70.
41. Horstrup K, Jablonka B, Hönig-Liedl P et al. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser 157 in intact human platelets correlates with fibrinogen receptor inhibition. Eur J Biochem 1994; 225: 21-7.
42. Huttenlocher K, Sandborg RR, Horwitz AF. Adhesion in cell migration. Curr Opin Cell Biol 1995; 7: 697-706.
43. Chakraborty T, Ebel E, Domann E et al. A focal adhesion factor directly linking intracellularly motile Listeria monocytogenes and Listeria invanovii to the actin-based cyto-skeleton of mammalian cells. EMBO J 1995; 14: 1314-21.
44. Pollard TD. Missing link for intracellular bacterial motility? Vasodilator-stimulated phosphoprotein (VASP) associates with virulence factors on the surface of intracellular bacteria; by binding to profilin, VASP may direct the actin assembly that appears to drive bacterial motility. Curr Biol 1995; 5: 837-40.
45. Reinhard M, Jouvenal K, Tripier D, Walter U. Identification, purification, and characterization of a zyxin-related protein that binds the focal adhesion and microfilament protein VASP (vasodilator-stimulated phosphoprotein). Proc Natl Acad Sci USA 1995; 92: 7956-60.
46. Reinhard M, Giehl K, Abel K et al. The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins. EMBO J 1995; 14: 1583-9.
47. Gertler FB, Niebuhr K, Reinhard M et al. Mena, a relative of VASP and drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 1996; 87: 227-39.
48. Pistor S, Chakraborty T, Walter U, Wehland J. The bacterial actin nucleator protein ActA of Listeria monocytogenes contains multiple binding sites for host microfilament proteins. Curr Biol 1995; 5: 517-25.
49. Higley S, Way M. Actin and cell pathogenesis. Curr Opin Cell Biol 1997; 9: 62-9.
50. Murad F. What are the molecular mechanisms for the antiproliferative effects of nitric oxide and cGMP in vascular smooth muscle? Circulation 1997; 95: 1101-3.
51. Eigenthaler M, Nolte C, Halbrügge M, Walter U. Concentration and regulation of cyclic nucleotide-dependent protein kinases and one of their major substrates in human platelets. Eur J Biochem 1992; 205: 471-81.
52. Pöhler D, Butt E, Meissner J et al. Expression, purification, and characterization of the cGMP-dependent protein kinases Ib and II using the baculovirus system. FEBS Lett 1995; 374: 419-25.
53. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the folin phenol reagent. J Biol Chem 1951; 193: 365-75.
54. Cornwell TL, Soff GA, Traynor AE, Lincoln TM. Regulation of the expression of cyclic GMP-dependent protein kinase by cell density in vascular smooth muscle cells. J Vasc Res 1994; 31: 330-7.
55. Heldin C-H. Simultaneous induction of stimulatory and inhibitory signals by PDGF. FEBS Lett 1997; 410: 17-21.
56. Desmouliere A, Gabbiani G. The cytoskeleton of arterial smooth muscle cells during human and experimental atheromatosis. Kidney Int 1992; 41: S87-9.
57. Gudi T, Huvar I, Meinecke M et al. Regulation of gene expression by cGMP-dependent protein kinase: transactivation of the c-fos promoter. J Biol Chem 1996; 271: 4597-600.
58. Sugimoto T, Haneda M, Togawa M et al. Atrial-natriuretic peptide induces the expression of MKP-1, a mitogen-activated protein kinase phosphatase, in glomerular mesangial cells. J Biol Chem 1996; 271: 544-7.